Vigene Biosciences, Inc is a leader in viral vector based gene delivery for both life science research, gene therapy and cell therapy purposes. Headquartered in Rockville, Maryland, Vigene offers AAV, lentivirus and adenovirus based products and custom services. Vigene offers FDA and EMA compliant cGMP production for lentivirus, adenovirus and AAV with proven technologies and track records.
Virovek Inc. is a world leader in large-scale research/GLP-grade AAV manufacturing. Located in Hayward, California, Virovek provides full services from construct design, gene cloning and AAV production that is purified and sterilized, ready for animal studies, at scales from 1e+13vg to 1e+17vg. Virovek’s proprietary AAV production technology is available for non-exclusive licensing for therapeutic development purposes. virovek.com
Jeffrey Hung, Ph.D. Chief Commercial Officer Vigene Biosciences 301-251-6638 [email protected]
Haifeng Chen, Ph.D. Chief Executive Officer Virovek 510-887-7121 [email protected]